68
Views
6
CrossRef citations to date
0
Altmetric
Letter

Nalmefene and alcohol dependence: A new approach or the same old unacceptable marketing?

&
Pages 75-80 | Published online: 29 Jun 2015
 

Disclosure

AB was co-investigator for the clinical trial ALPADIR (baclofen). BG has no conflict of interest related to this communication.

Disclosure

Francois Paille is a consultant for Ethypharm and Lundbeck and has received honoraria from Ethypharm and Lundbeck, speaker fees from Lundbeck and Merck Serono and travel grants from Lundbeck. Hervé Martini has received honoraria from Lundbeck, speaker fees from Lundbeck, and travel grants from Reckitt-Benckiser and Lundbeck.